NIH


Framingham for the Modern Era: Josie Briggs on the Precision Medicine Initiative

Josie Briggs is Director of the National Center for Complementary and Integrative Health (NCCIH) at the NIH. She is also currently serving as interim director of the president’s new Precision Medicine Initiative (PMI).

What has happened since the president announced the initiative, what is the proposed timeline going forward, and how much money will there be for the project ongoing?

Josie answers these questions and more in today’s show, comparing the PMI to the well known Framingham Heart Study, probably the nation’s greatest longitudinal study to date. As with the Framingham study, the NIH is hoping that the PMI will engage the general public in biomedical research.

“Having the interest of the public in clinical research, and having people sign up and be engaged and say that they want to be a part of this is, to me, a very important component. In some disease areas, it’s striking how few people participate in clinical research. This is — and the president’s enthusiasm is part of it — this is a way for there to be broader engagement in clinical research,” says Josie.

Is Bad Science Undermining Big Science? A Conversation Between Guests and Audience

One can look at funding for science and break it up into Big and Small Science. Funders of Big Science would be large corporations, foundations, and the government, whereas Small Science relies on VC, startup funds, small businesses and entrepreneurs. Big Science comprises those big projects like the sequencing of the human genome and the war on cancer. But are such big projects yielding results that justify the massive spending?



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup